Head-To-Head Comparison: Senestech (NASDAQ:SNES) versus TerrAscend (OTCMKTS:TSNDF)

Senestech (NASDAQ:SNES) and TerrAscend (OTCMKTS:TSNDF) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, profitability, institutional ownership, analyst recommendations, dividends and earnings.

Analyst Recommendations

This is a breakdown of recent ratings and target prices for Senestech and TerrAscend, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Senestech	1	1	0	1	2.33
TerrAscend	0	0	0	2	4.00

Senestech currently has a consensus target price of $10.00, indicating a potential upside of 201.20%. Given Senestech’s higher probable upside, analysts plainly believe Senestech is more favorable than TerrAscend.

Valuation and Earnings

This table compares Senestech and TerrAscend”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Senestech	$1.86 million	8.82	-$6.18 million	($5.44)	-0.61
TerrAscend	$306.68 million	0.70	-$80.23 million	($0.41)	-1.71

Senestech has higher earnings, but lower revenue than TerrAscend. TerrAscend is trading at a lower price-to-earnings ratio than Senestech, indicating that it is currently the more affordable of the two stocks.

Volatility and Risk

Senestech has a beta of 0.42, indicating that its share price is 58% less volatile than the S&P 500. Comparatively, TerrAscend has a beta of 1.47, indicating that its share price is 47% more volatile than the S&P 500.

Profitability

This table compares Senestech and TerrAscend’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Senestech	-289.01%	-150.93%	-111.41%
TerrAscend	-40.86%	-23.19%	-6.35%

Insider & Institutional Ownership

5.2% of Senestech shares are owned by institutional investors. Comparatively, 5.8% of TerrAscend shares are owned by institutional investors. 5.3% of Senestech shares are owned by insiders. Comparatively, 32.2% of TerrAscend shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

TerrAscend beats Senestech on 10 of the 14 factors compared between the two stocks.

About Senestech

SenesTech, Inc. develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.

About TerrAscend

TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures vaporizables, concentrates, topicals, tinctures and edibles. It also operates retail dispensaries under the Apothecarium and State Flower brand names. The company was incorporated in 2017 and is headquartered in Mississauga, Canada.